Carl June, Richard W. Vague Professor in Immunotherapy in PSOM’s department of pathology and laboratory medicine and director of both the Center for Cellular Immunotherapies in the Abramson Cancer Center and the Parker Institute for Cancer Immunotherapy, was recently named to Time magazine’s list of 100 most influential people. The list recognizes the activism, innovation and achievement of the world’s most influential individuals and is honoring Dr. June for his pioneering work in developing CAR T therapy, which was recently approved for a second indication by the U.S. Food and Drug Administration for the treatment of patients with certain forms of non-Hodgkin’s lymphoma. That follows the initial FDA approval for treatment of acute lymphoblastic leukemia in certain pediatric and young adult patients last year.

Dr. June has received numerous honors and awards. He was most recently named a 2017 Fellow of the American Association for Cancer Research Academy (Almanac April 18, 2017), and he was given the David A. Karnofsky Memorial Award from the American Society of Clinical Oncology (Almanac August 29, 2017).